BioSig Technologies, Inc.
  • Home
  • About BioSig
    • About BioSig
    • Overview
    • Partnerships
  • Our Technology
    • Our Technology
    • The PURE EP Platform
      • Overview
      • ATC
      • NFT
    • Publications
  • Join Our Team
  • News & Media
    • News & Media
    • Overview
    • Press Releases
    • BioSig in the News
    • Events
  • Investors
    • Investors
    • Overview
    • News / Events
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Information
      • Profile
      • Leadership Team
      • Contacts
      • FAQ
    • Financial Information
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Corporate Governance
      • Board of Directors
      • Governance Documents
  • Contact
News & Media

News & Media

  • Overview
  • Press Releases
  • BioSig in the News
  • Events

Press Releases

BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform

April 14, 2021

BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study

April 13, 2021

BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)

April 9, 2021

EP Lab Digest Features Physician Experience with BioSig’s Cardiac Signal Acquisition Technology

April 8, 2021

BioSig lands Commercial Sales to Leading Hospital System

April 6, 2021

BioSig Technologies, Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference

April 5, 2021

BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing Technology

March 30, 2021

BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021

March 29, 2021

BioSig CEO Kenneth L. Londoner to Present at the Benzinga Biotech Small Cap Conference

March 19, 2021

BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare Conference

March 10, 2021
  • Previous
    • 1...
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 16
    • ...36
    Next
    Award
    BioSig Technologies, Inc.
    Sign Up for BioSig Updates Contact Us
    x formerly known as twitter icon X formerly known as Twitter
    linkedin Facebook
    © 2025 BioSig Technologies, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap